Ayana Pharma
PrivateLast Round
Seed
Oct 1, 2011
Company Overview
Ayana Pharma is a pharmaceutical company that develops and manufactures liposomal therapeutics for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ayana Pharma Comparables
Compare Ayana Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 77% | |
| ForDoz Pharma Corp. | 76% | |
| Sun Pharma | 75% |
For institutional investors. Book with your work email.
Ayana Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2011 |
For institutional investors. Book with your work email.
Ayana Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Continuing Education Fund for Teachers and Kindergarten Teachers | Seed |
| Ilan Holdings | Seed |
| Integra Holdings | Seed |
| Yissum Research Development Company of the Hebrew University of Jerusalem | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors grew 92% MoM, reaching 1.1K.
- May 4, 2025
Monthly visitors increased 82% MoM.
For institutional investors. Book with your work email.
Ayana Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ayana Pharma's valuation, stock price, and market status.
Is Ayana Pharma a public or private company?
Ayana Pharma is a private company.
What is the current stock price of Ayana Pharma?
Ayana Pharma is a private company, so its shares have no public market price. Caplight tracks Ayana Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ayana Pharma worth (valuation)?
Valuation information for Ayana Pharma is not publicly available.
Can I buy Ayana Pharma stock?
Ayana Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ayana Pharma's last funding round?
Ayana Pharma's most recent funding round was Seed on October 1, 2011.
Who are the main investors in Ayana Pharma?
Key investors in Ayana Pharma include Continuing Education Fund for Teachers and Kindergarten Teachers, Ilan Holdings, Integra Holdings, Yissum Research Development Company of the Hebrew University of Jerusalem.
Will Ayana Pharma IPO soon?
No public IPO plans have been announced for Ayana Pharma.
How can I track Ayana Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Ayana Pharma's shares on secondary markets.